…r 12 months for subacute SLE and had a complete renal response. Anifrolumab was added to her. A complete renal response had 4 of the 11 pat…
anifrolumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning anifrolumab
42 articles · page 4 of 4…A 1:1280, anti-dsDNA positive, low C3/C4). Initial therapy with hydroxychloroquine (200 mg/day) and low-dose prednisone (7.5 mg/day) achieved clin…
…pressant, 36 (13.3%) Belimumab, 14 (5.2%) Anifrolumab, 4 (1.5%) Rituximab, and only 46 (17%) glucocorticoids, of whom 80.4% were on doses…
…nalysis included the aggregated placebo arms from phase 2 and 3 anifrolumab trials (MUSE, TULIP-1, TULIP-2) in moderate-to-severe SLE. Phys…
…s pooled individual patient data from the placebo arms of three anifrolumab trials (MUSE, TULIP-1, TULIP-2). The SLE-DAS RI was defined as …
…A, anti Ro52 and low titer of IgM-RF) is initially treated with hydroxychloroquine, azathioprine and topical steroids. Because of insufficient imp…